Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

The Guardian·Jun 2

This story is reported by The Guardian. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Research shows weight-loss drugs may also reduce cancer risk

PBS·Jun 19

2

GLP-1 use linked to lower breast cancer incidence in large cohort study

Penn Medicine·Jun 2

3

Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs

Memorial Sloan Kettering Cancer Center·Mar 10

4

5 New Findings About GLP-1s and Breast Cancer

Breast Cancer.org·Mar 12

5

Weight-loss drugs linked to lower breast cancer risk, study finds

Euronews.com·Jun 4

6

Weight-loss drugs linked to lower breast cancer rates. What to know

USA Today·Jun 2

7

Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30%

Healthline·Jun 3

8

Weight loss drugs and cancer: what we know so far

Cancer Research UK - Cancer News·Feb 5